Asthma Clinical Trials

Showing 3941-3960 of 4,312 trials

Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol

NCT00685425

The purpose of this study is to investigate, using an exercise challenge approach, the dose response of levalbuterol HFA MDI in adolescent and adult subjects with asthma

AsthmaBronchoconstriction

Sumitomo Pharma America, Inc.62 participantsStarted Oct 2002

Los Angeles, California, United States • Signal Hill, California, United States • Denver, Colorado, United States +2 more locations

COMPLETEDPhase 2

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

NCT00685022

The purpose of this study is to compare the safety and tolerability of levalbuterol HFA metered dose inhaler (MDI) versus racemic albuterol HFA MDI.

Asthma

Sumitomo Pharma America, Inc.49 participantsStarted Jun 2003

Encinitas, California, United States • North Dartmouth, Massachusetts, United States • St Louis, Missouri, United States

COMPLETEDPhase 3

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

NCT00583986

This is a study to investigate the reliability, ruggedness and safety of the top mounted actuation indicator (TMAI) when used with Levalbuterol HFA MDI.

AsthmaChronic Obstructive Pulmonary DiseaseCOPD

Sumitomo Pharma America, Inc.150 participantsStarted Sep 2005

Encinatas, California, United States • Huntington Beach, California, United States • Mesa, California, United States +23 more locations

Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

Related Searches

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Persistence of Airway Inflammation and Remodeling in Subjects With Symptomatic or Complete Asthma Remission

Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma

Coping Skills Training (CST) for Children With Chronic Health Conditions

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma

Pressure-limited Ventilation Versus Volume-targeted Ventilation in Preterm Newborns

Will CPAP Reduce Length Of Respiratory Support In Premature Infants?

The Use of Fractional Exhaled Nitric Oxide in the Identification of Non-adherence in Difficult Asthma

Withdrawal of Non-invasive Ventilation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Acute Hypercapnic Respiratory Failure

Fibreoptic Intubation With and Without Sellick´s Maneuver

Correlation Between IgE Parameters and the Response to Omalizumab in Subjects With Severe Asthma

Comparison of Two Treatment Regimens in Asthmatic Patients

Effect of Montelukast on the Airway Remodeling

Bacille Calmette-Guérin (BCG) Vaccine and Atopy

Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France

Electronic Health Record (EHR) Decision Support to Improve Outpatient Asthma Care

Budesonide for Emergency Treatment of Acute Wheezing in Children